Seroatlas · Human Serome Atlas

ATP5F1A

ATP synthase F(1) complex subunit alpha, mitochondrial

Also known as: ATP5A, ATP5A1, ATP5AL2, ATPA_HUMAN, ATPM, hATP1, OMR, ORM

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P25705
Gene
ATP5F1A
Ensembl
ENSG00000152234
Chromosome
18
Canonical length
553 aa
Protein class
Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
Subcellular location
Mitochondria,End piece
Quaternary structure
Homooctamer

OverviewNCBI Gene

This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, using an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and a single representative of the other 3. The proton channel consists of three main subunits (a, b, c). This gene encodes the alpha subunit of the catalytic core. Alternatively spliced transcript variants encoding the different isoforms have been identified. Pseudogenes of this gene are located on chromosomes 9, 2, and 16. [provided by RefSeq, Mar 2012]

Canonical amino-acid sequenceUniProt

553 residues, UniProt reviewed canonical sequence.

>P25705|ATP5F1A
     1  MLSVRVAAAV VRALPRRAGL VSRNALGSSF IAARNFHASN THLQKTGTAE MSSILEERIL
    61  GADTSVDLEE TGRVLSIGDG IARVHGLRNV QAEEMVEFSS GLKGMSLNLE PDNVGVVVFG
   121  NDKLIKEGDI VKRTGAIVDV PVGEELLGRV VDALGNAIDG KGPIGSKTRR RVGLKAPGII
   181  PRISVREPMQ TGIKAVDSLV PIGRGQRELI IGDRQTGKTS IAIDTIINQK RFNDGSDEKK
   241  KLYCIYVAIG QKRSTVAQLV KRLTDADAMK YTIVVSATAS DAAPLQYLAP YSGCSMGEYF
   301  RDNGKHALII YDDLSKQAVA YRQMSLLLRR PPGREAYPGD VFYLHSRLLE RAAKMNDAFG
   361  GGSLTALPVI ETQAGDVSAY IPTNVISITD GQIFLETELF YKGIRPAINV GLSVSRVGSA
   421  AQTRAMKQVA GTMKLELAQY REVAAFAQFG SDLDAATQQL LSRGVRLTEL LKQGQYSPMA
   481  IEEQVAVIYA GVRGYLDKLE PSKITKFENA FLSHVVSQHQ ALLGTIRADG KISEQSDAKL
   541  KEIVTNFLAG FEA

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ATP5F1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
1,644 nTPM

Expression across tissuesHPA

Tissue

  • tongue: 1,644 nTPM
  • skeletal muscle: 1,501 nTPM
  • heart muscle: 1,409 nTPM
  • parathyroid gland: 815 nTPM
  • choroid plexus: 760 nTPM
  • kidney: 682 nTPM

Single-cell type

  • parietal cells: 912 nCPM
  • cytotrophoblasts: 910 nCPM
  • esophageal suprabasal cells: 840 nCPM
  • migrating cytotrophoblasts: 804 nCPM
  • esophageal basal cells: 785 nCPM
  • syncytiotrophoblasts: 594 nCPM

Immune cell

  • total PBMC: 1,340 nTPM
  • myeloid DC: 961 nTPM
  • classical monocyte: 575 nTPM
  • T-reg: 529 nTPM
  • intermediate monocyte: 513 nTPM
  • naive CD4 T-cell: 505 nTPM

Brain region

  • choroid plexus: 620 nTPM
  • cerebral cortex: 291 nTPM
  • hypothalamus: 288 nTPM
  • midbrain: 276 nTPM
  • medulla oblongata: 265 nTPM
  • cerebellum: 260 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about ATP5F1A.

Disease | AllUniProt

Conditions ATP5F1A is implicated in, by any mechanism.

Disease | GeneticClinVar

5 pathogenic / likely-pathogenic of 314 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.18
gnomAD pLI
1
DepMap mean gene effect
-0.67
DepMap dependency class
common

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ATP5F1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ATP5F1A as an antibody target. Whether an autoantibody or antibody against ATP5F1A could matter depends on whether native ATP5F1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ATP5F1A is annotated at the cell surface, where native ATP5F1A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label ATP5F1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ATP5F1A. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...